Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00473707 · ClinicalTrials.gov registry record · NA
Active Versus Expectant Management of the Third Stage of Labor
A NA study of Postpartum Hemorrhage, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- NA
- Development phase
- 218
- Enrollment target
- 1
- Study location
NCT00473707 is a NA study of Postpartum Hemorrhage that has completed, run by Christiana Care Health Services. The registered enrollment target is 218 participants, above the 185-participant average among 11 other Postpartum Hemorrhage trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00473707, a NA study of Postpartum Hemorrhage, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 218 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if giving oxytocin immediately after delivery causes less bleeding, transfusion needs and hastens delivery of placenta.
Conditions Studied
Interventions
- DRUG Oxytocin
- PROCEDURE Active management of the third stage of labor
- PROCEDURE Expectant management of the third stage of labor
- DRUG Oxytocin and gentle cord traction with fundal massage
Study Locations (1)
Delaware
- Christiana Care Health System - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00473707
The ClinicalTrials.gov registry entry for NCT00473707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 185-participant average among 11 other Postpartum Hemorrhage trials with a reported enrollment target (18% higher). The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 4 interventions - of which Oxytocin is the first listed.
NCT00473707 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT00473707 about?
NCT00473707 is a clinical study titled "Active Versus Expectant Management of the Third Stage of Labor". The purpose of this study is to determine if giving oxytocin immediately after delivery causes less bleeding, transfusion needs and hastens delivery of placenta.
What is the current status of trial NCT00473707?
This trial is currently completed. It is a NA study. The enrollment target is 218 participants. The study started on 2002-08. Estimated completion is 2006-07.
What conditions does trial NCT00473707 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage.
What interventions are being tested in trial NCT00473707?
The interventions under investigation include: Oxytocin (DRUG), Active management of the third stage of labor (PROCEDURE), Expectant management of the third stage of labor (PROCEDURE), Oxytocin and gentle cord traction with fundal massage (DRUG).
Who is sponsoring clinical trial NCT00473707?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00473707 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping
COMPLETED · NA
-
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
COMPLETED · NA
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
COMPLETED · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
-
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.